Sustained complete remission of advanced hepatocellular carcinoma with sorafenib therapy

E-ISSN： 1751-2980|16|9|537-540

ISSN： 1751-2972

Source： Journal of Digestive Diseases, Vol.16, Iss.9, 2015-09, pp. : 537-540

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib

By Yau Thomas Pang Roberta Chan Pierre Poon Ronnie T

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 13, 2010-09 ,pp. : 2187-2198

Informa Healthcare

Access to resources Recommend Favorite

Sorafenib: A Review of its Use in Advanced Hepatocellular Carcinoma

By Keating Gillian M.

Drugs, Vol. 69, Iss. 2, 2009-01 ,pp. : 223-240

Adis International

Access to resources Recommend Favorite

Sorafenib: a guide to its use in advanced hepatocellular carcinoma

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 25, Iss. 10, 2009-10 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite

Sequential therapy with sunitinib and sorafenib in metastatic hepatocellular carcinoma

By Ahn Hee

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1768-1772

Springer Publishing Company

Access to resources Recommend Favorite

Beyond sorafenib: novel targeted therapies for advanced hepatocellular carcinoma

By Zhu Andrew X

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 5, 2010-05 ,pp. : 663-672

Informa Healthcare

Access to resources Recommend Favorite